Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

Additionally, the Phase 1 clinical trial evaluating QTX3034, an oral G12D-preferring multi-KRAS inhibitor, as a monotherapy and in combination with cetuximab, continues to enroll patients, and data is ...

Cell competition in epithelial tissue eliminates transformed cells expressing activated oncoproteins to maintain epithelial homeostasis. Although the process is now understood to be of mechanochemical ...

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

Sales of these and other alt proteins, which tasted and had the texture of hamburgers but used plant-based ingredients, had risen 27% over the year, and Burger King and McDonald’s had added them ...

Recent data indicate that the Ras-like RAP1 protein and various Rho proteins crosstalk to polarity proteins to induce spatially restricted cytoskeletal remodelling. This is required for cell ...

These findings should not be used as an excuse not to optimize renin–angiotensin system inhibition and target urinary protein in patients ... effect facilitated by RAS inhibition, particularly ...

In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...

G protein-coupled receptors (GPCRs), crucial for diverse physiological responses, have traditionally been investigated in ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

Among the many metrics available, Relative Athletic Score (RAS) has emerged as a prominent tool in assessing a prospect’s athleticism. Developed by Kent Lee Platte, RAS has transformed how ...

A study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal ...